Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.
Read More
1 minute read

Edwards Lifesciences Presents 5-Year Follow Up Data From PARTNER Trials Showing Clinical Outcomes For Female And Small Annulus Patients With Transcatheter Aortic Valve Replacement At The New York Valves 2024: The Structural Heart Summit

By Benzinga Newsdesk
June 5, 11:48 AM
Edwards Lifesciences (NYSE:EW) today announced the results from an analysis of data from the PARTNER Trials examining outcomes of transcatheter aortic valve replacement (TAVR) patients with a small annulus. Through

EW

Read More
2 minute read

BD Bolsters Portfolio With $4.2B Cash Deal For Edwards Lifesciences’ Critical Care Group: Details

By Shivani Kumaresan
June 3, 12:02 PM
BD (Becton, Dickinson and Company) will acquire Edwards Lifesciences' Critical Care product group for $4.2 billion in cash. This acquisition enhances BD's portfolio with advanced AI-enabled monitoring technologies, aiming to improve patient outcomes in critical care settings. The transaction is expected to boost BD's financial performance, delivering immediate accretive benefits and long-term revenue growth.

BDX